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Several types of cancer cells produce polypeptide growth factors and often the same cells have functional 
receptors for the released growth factor (autocrine secretion). We have studied expression of genes encoding 
somatomedin-C/insulin-like growth factor-I (Sm-C/IGF-I) and IGF-II, in rat medullary thyroid carcinomas 
(MTCs) in different stages of tumour differentiation. RNAs hybridizing specifically to an IGF-I cDNA 
probe were detected in 6 out of 7 differentiated MTCs and IGF-II related RNAs were demonstrated in 5 
out of these 7 differentiated MTCs. In 5 anaplastic MTCs no IGF RNAs were detected, except for a small 
amount of IGF-II related RNA in one tumour. 
Insulin-like growth factor; Gene expression; Northern blotting; Tumor differentiation; 
(Rat medullary thyroid carcinoma) 
1. INTRODUCTION 
'Autocrine secretion' by cancer cells has been 
demonstrated for transforming rowth factors o~ 
and ~, platelet derived growth factor and 
bombesin [1-3]. This mechanism enables these 
cells to establish autonomous growth without the 
need for 'external' growth factors. 
An autocrine system involving somatomedin- 
C/insulin-like growth factor-I (Sm-C/IGF-I)  has 
been suggested for human osteosarcoma cell lines, 
which were shown to produce immunoreactive 
IGF-I [4]. Because of the high degree of nucleotide 
sequence conservation between human and rodent 
IGF-genes, the availability of cDNA probes en- 
coding human IGF-I [5] and IGF-I I  [6], allowed us 
to study expression of these genes in rat tissues. 
Medullary thyroid carcinoma (MTC) is a 
tumour originating from the calcitonin (CT) pro- 
ducing C-cells of the thyroid gland [7]. Rats of the 
Wag/Rij strain spontaneously develop these 
tumours. After sequential transplantations some 
of these tumours become anaplastic. They show an 
increased growth rate and secrete smaller amounts 
of CT [8]. Using Northern blot hybridization 
analysis, we examined the presence of RNAs en- 
coding IGF-I, IGF-I I  and CT in both types of rat 
MTC. 
2. MATERIALS AND METHODS 
Correspondence address: J.W.M. H6ppener, Institute 
of Molecular Biology, State University of Utrecht, 8 
Padualaan, 3584 CH Utrecht, The Netherlands 
2.1. RNA isolation and Northern blotting 
Total cellular RNA was isolated from rat MTCs 
and adult rat liver, by centrifugation of a tissue 
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homogenate through a cesium chloride cushion 
[9]. Poly(A)-enriched RNA was prepared by one 
cycle of oligo(dT)-cellulose column chromatog- 
raphy [10]. RNA preparations were denatured with 
glyoxal, size-fractionated electrophoretically on 
1.4°70 agarose gels, transferred onto Gene Screen 
membranes by Northern blotting [11], and hybri- 
dized to 32p-labelled probes. 
2.2. DNA probes and hybridization 
As an IGF-I specific probe we have used plasmid 
plGF-I  [5], containing a 777 base pairs (bp) cDNA 
sequence, encoding the complete amino acid se- 
quence of human IGF-I. The extent of nucleotide 
sequence homology between human and rat IGF-I 
RNA is not exactly known. However, since human 
IGF-I probes show cross-hybridization with 
Chinese hamster [12] and mouse [13] genomic 
DNA, we assumed that the human IGF-I cDNA 
could be used as a specific probe for rat IGF-I 
RNA. In addition, an extensive conservation of the 
amino acid sequence in the N-terminal parts of rat 
and human IGF-I has been demonstrated [14]. 
As an IGF-I I  specific probe we have used 
plasmid plGF- I I  var [6], containing a 713 bp 
cDNA sequence, encoding the complete amino 
acid sequence of a variant human IGF-I I .  Since the 
nucleotide sequence homology between the coding 
regions of human IGF-I I  var and rat IGF- 
I I /multiplication stimulating activity (MSA) 
cDNA is 84°7o [6,15], our human IGF-I I  var cDNA 
was considered to be a suitable probe for detecting 
rat IGF- I I /MSA related RNAs. Previous ex- 
periments have shown that the IGF-I and IGF-I I  
cDNA probes do not cross-hybridize under the 
conditions as employed in the present study. In ad- 
dition, the synthetic 20-mer oligonucleotide 
5 ' -ACTGAAGCGTGTCAACAAGC-3 '  comple- 
mentary to nucleotides 1171-1190 of the rat 
mRNA encoding MSA [15] was used as a probe. 
As a CT-specific probe we have used plasmid 
pCal [16], containing a 627 bp long insert of rat 
CT cDNA (obtained from Dr M.G. Rosenfeld). 
Double-stranded DNA probes were labelled with 
32p by nick-translation to a specific activity of 
108 dpm per /zg DNA. The MSA-specific 
oligonucleotide was labelled 5'-terminally with 
[7-32P]ATP and Tn-polynucleotide kinase. 
Hybridizations were performed in the presence of 
50°7o formamide and 6 × standard saline citrate 
(SSC) at 42°C (30°C for the oligonucleotide) for 
18 h. Filters were washed twice at 65°C (32°C for 
the oligonucleotide) in 2 × SSC-0.5O70 SDS for 
30 min, and exposed to Fuji RX films. 
The sizes of RNA molecules hybridizing to the 
probes were determined by coelectrophoresis of
molecular mass standards (HindlII-digested 
ADNA and HaelII-digested ~X 174 DNA). 
3. RESULTS AND DISCUSSION 
The results have been summarized in table 1. 
In 6 out of 7 differentiated MTCs examined, 
hybridization of the IGF-I specific probe to an 
RNA species of approx. 7000 nucleotides was 
observed. In addition, IGF-I related RNAs of 2000 
and 1000 nucleotides were detected in 5 and 2 of 
these tumours, respectively. The 7000 nucleotides 
long RNA species could also be demonstrated in
adult rat liver, where IGF-I is known to be syn- 
thesized (fig. 1A). Since the hybridization signal is 
much stronger in the poly(A)-enriched RNA 
preparations from differentiated MTCs and liver 
than in the total cellular RNA preparations, we 
conclude that the hybridizing RNAs are 
polyadenylated. Whether the differently sized 
RNA species are transcripts of different rat IGF-I 
genes or represent alternatively processed 
Table 1 
Presence and size (in nucleotides) of IGF-I, IGF-II and 
CT related RNA species in rat MTCs and rat liver, as 
revealed by Northern blot hybridization analysis 
Probe Tissue 
Differentiated Anaplastic Adult 
MTC MTC liver 
IGF-I 7000 (6/7) a 7000 
2000 (5/7) _b (5/5) 1700 
1000 (2/7) 1300 
600 
IGF-II var 3800-4300 (5/7) 2800 (1/5) 
CT 3000 (7/7) 
1050 (7/7) - (5/5) 
a Number of tumours in which the specific RNA species 
was detected/total number of tumours of that type 
investigated 
b - ,  not detected 
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Fig.l. Detection of IGF-I, IGF-II and calcitonin related 
transcripts in RNA preparations from rat MTCs and rat 
liver. Total cellular (T) and poly(A)-enriched (A+) RNA 
preparations (20/~g per lane) include those from (lanes): 
a differentiated rat MTC (1, 2, 7 and 8); an anaplastic 
rat MTC (3 and 4); an adult rat liver (5 and 6). The size 
(in nucleotides) of hybridizing RNA species and the 
positions of 28 S and 18 S ribosomal RNAs are 
indicated. (A) Hybridization with the 777 base pairs (bp) 
PstI insert of plasmid pIGF-I. The blot was exposed for 
13 days with an intensifying screen. Lanes 5 and 6 were 
exposed for 2 days with an intensifying screen. (B) 
Hybridization with the 713 bp PstI insert of plasmid 
pIGF-II var. Lanes 1 and 2 were exposed for 18 h with 
an intensifying screen, lanes 3-8 were exposed for 3 days 
with an intensifying screen. The 2800 nucleotides long 
IGF-II related RNA can hardly be seen in lane 4, but it 
was clearly visible on the original autoradiographs. (C) 
Hybridization with the plasmid pCal, containing a 
627 bp insert of rat CT cDNA. Lanes 1 and 2 were 
exposed for 2 h with an intensifying screen, lanes 3-6 
were exposed for 3 days with an intensifying screen. 
transcripts of  a single gene is not known. We and 
others [12,13,17,18] have shown that he human 
genome contains a single IGF- I  gene, which is 
located on chromosome 12. However,  this does 
not preclude the occurrence of  mult iple genes in 
other species. 
IGF- I I  related poly(A) RNAs  were demonstrat -  
ed in 5 out o f  7 di f ferent iated MTCs,  but not in 
adult  rat liver ( f ig. lB).  In di f ferent iated MTCs 
four species of  IGF- I I  RNA are found in the range 
of  3800-4300 nucleotides. 
In 5 anaplast ic rat MTCs no IGF- I  encoding 
RNAs could be detected. However,  an IGF- I I  
related RNA was demonstrated in 1 out of  these 5 
tumours.  Interestingly, the size of  the IGF- I I  RNA 
molecules is dissimilar for the two types of  MTC.  
In the anaplast ic MTC the IGF- I I  RNA is approx.  
2800 nucleotides long. Hybr id izat ion of  RNA 
from dif ferentiated rat MTCs to the rat MSA 
specific ol igonucleotide, revealed four RNA 
species with the same length as detected by the 
human IGF- I I  cDNA probe (f ig. lB).  In RNA 
preparat ions of  the IGF- I I  positive anaplast ic rat 
MTC,  the MSA-specif ic  ol igonucleotide did not 
reveal the 2800 nucleotides long RNA species 
detected with the human cDNA probe, probab ly  
because of  its low abundancy.  We and others 
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[13,18,19] have shown that in humans there is only 
a single IGF-II gene, which is located on 
chromosome 11. However, two closely related 
types of cDNA molecules, encoding precursors of 
IGF-II and a variant of IGF-II (IGF-II var) have 
been isolated from the same human liver cDNA 
library [6]. The presence of different RNA species 
hybridizing to an IGF-II specific probe in rat MTC 
tissue, might be explained by alternative splicing or 
usage of different promoter and/or polyadenyla- 
tion signals. On the other hand, it might point to 
the existence of related but as yet unknown rat 
IGF-II genes. In this respect it is important to note 
that both developmental and tissue-specific expres- 
sion of several rat pre-pro-IGF-II related 
transcripts have been reported [20]. 
Differentiated as well as anaplastic rat MTCs 
have been reported to contain the polypeptide hor- 
mone CT [8]. However, we were able to 
demonstrate he presence of CT-encoding mRNA 
in differentiated MTCs only (fig. IC, table 1). This 
indicates that CT mRNA production in anaplastic 
MTCs is below the level of detection on Northern 
blots and might be used as a biochemical marker 
for distinguishing differentiated MTC from the 
anaplastic type. 
The presence of IGF-like peptides in normal rat 
thyroid glands has not yet been reported. IGF-I 
was undetectable by immunoperoxidase staining of 
thyroid tissue sections from man and growth 
hormone-treated Little mouse [21]. Therefore the 
question remains open whether the rat MTC 
tumours might originate from cells that produce 
IGFs in the normal thyroid gland, or that IGF 
RNA production is a newly acquired characteristic 
of the transformed MTC cells. 
If the rat MTCs are capable of producing IGFs, 
it will be interesting to study whether the IGF- 
producing cells have functional receptors for these 
polypeptide growth factors. If so, autocrine secre- 
tion of IGFs by rat MTCs might prove to be a 
useful model for physiological experiments study- 
ing functional relations between IGF production 
and tumourigenesis or tumour progression. 
It was recently demonstrated that human breast 
cancer cells in culture secrete an IGF-I-like protein 
and that hese cells were growth stimulated by 
serum-derived IGF-I [22]. It was already known 
that several human breast cancer cell lines have cell 
surface receptors for IGF-I [23]. These results sug- 
gest that IGF-I can be involved in an autocrine 
system of cell proliferation in breast cancer cells. 
The detection of IGF-I related RNAs in dif- 
ferentiated rat MTCs represents one of the first 
demonstrations of IGF-I RNA in tumour tissue. 
IGF-II RNA has recently been demonstrated in
human Wilms tumours, rhabdomyosarcomas and 
various normal tissues [24,25]. 
The fact that IGF-I RNA production can be 
detected (although in small amounts) in the ma- 
jority of tumours of the differentiated type of rat 
MTC but not in the anaplastic type, might be an 
important clue to the molecular and cellular basis 
of tumour differentiation and malignancy and 
perhaps even differentiation i general, since IGF- 
I synthesis and IGF-II synthesis are under different 
control and they presumably have different 
biological functions in vivo [26]. In particular, 
IGF-II (MSA) might have a more pronounced role 
in the fetal organism, while Sm-C/IGF-I is the 
predominant somatomedin postnatally. 
As described by others, IGF-II RNA can easily 
be detected in a variety of fetal and neonatal rat 
and human tissues, but can hardly be detected in 
adult rat, mouse and human liver [20,25], even 
though the liver is considered to be one of the ma- 
jor sites of IGF-II production in adult organisms 
[25]. IGF-II RNA was undetectable in adult rat 
liver in our experiments. These results suggest that 
the relatively large amount of IGF-II RNA 
detected in differentiated rat MTCs reflects a 
tumour-specific activation or enhanced expression 
of (an) IGF-II gene(s) in this type of neoplasm. 
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